Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Young Innovations, Inc. (“Young” or the “Company”) (Nasdaq: YDNT) relating to the proposed acquisition by Linden Capital Partners (“Linden”). Under the terms of the transaction, Young shareholders will receive only $39.50 in cash for each share of Young stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Young for not acting in the Company’s shareholders' best interests in connection with the sale process to Linden. The transaction may undervalue the Company and will not result in a substantial gain for many shareholders. For example Young stock traded at $39.79 on September 27, 2012 and $39.95 as recently as December 4, 2012. In addition, Young may solicit competing bids only through January 12, 2013. If you own shares of Young stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at firstname.lastname@example.org visiting http://brodsky-smith.com/513-ydnt-young-innovations-inc.html, by calling toll free 877-LEGAL-90.